» Articles » PMID: 38921408

Neutrophil Oxidative Burst Profile Is Related to a Satisfactory Response to Itraconazole and Clinical Cure in Feline Sporotrichosis

Abstract

Despite the central role of cats in the transmission and amplification of , studies regarding immune response in feline sporotrichosis are scarce. In cats with sporotrichosis, neutrophil-rich lesions are usually associated to good general condition and lower fungal burden. However, the role of neutrophils in anti- immunity has been little explored in cats. Thus, the aim of this study was to evaluate the neutrophil oxidative burst in the blood of cats with sporotrichosis. Cats with sporotrichosis included in the study were treated with itraconazole (ITZ) alone or combined with potassium iodide (KI). The neutrophil oxidative burst was evaluated through a flow-cytometry-based assay using dihydrorhodamine 123 (background) and stimulation with Zymosan and heat-killed yeasts. The cure rate was 50.0% in cats under treatment with ITZ monotherapy and 90.9% in cats treated with ITZ + KI ( = 0.014), endorsing the combination therapy as an excellent alternative for the treatment of feline sporotrichosis. Higher percentages of -stimulated neutrophils were associated with good general condition ( = 0.003). Higher percentages of - ( = 0.05) and Zymosan-activated ( = 0.014) neutrophils before and early in the treatment were related to clinical cure in ITZ-treated cats. The correlation between oxidative burst and successful use of KI could not be properly assessed given the low number of failures ( = 2) in this treatment group. Nasal mucosa involvement, typically linked to treatment failure, was related to lower percentages of activated neutrophils in the background at the treatment outcome ( = 0.02). Our results suggest a beneficial role of neutrophils in feline sporotrichosis and a positive correlation between neutrophil activation and the cure process in ITZ-treated cats.

Citing Articles

Application of Principal Component Analysis as a Prediction Model for Feline Sporotrichosis.

Pegoraro F, Mangrich-Rocha R, Weber S, de Farias M, Schmidt E Vet Sci. 2025; 12(1).

PMID: 39852907 PMC: 11768719. DOI: 10.3390/vetsci12010032.

References
1.
Klebanoff S . Myeloperoxidase: friend and foe. J Leukoc Biol. 2005; 77(5):598-625. DOI: 10.1189/jlb.1204697. View

2.
Almeida-Paes R, Figueiredo-Carvalho M, Brito-Santos F, Almeida-Silva F, Oliveira M, Zancope-Oliveira R . Melanins Protect Sporothrix brasiliensis and Sporothrix schenckii from the Antifungal Effects of Terbinafine. PLoS One. 2016; 11(3):e0152796. PMC: 4816517. DOI: 10.1371/journal.pone.0152796. View

3.
de Miranda L, Silva J, Gremiao I, Menezes R, Almeida-Paes R, Guerino Dos Reis E . Monitoring Fungal Burden and Viability of spp. in Skin Lesions of Cats for Predicting Antifungal Treatment Response. J Fungi (Basel). 2018; 4(3). PMC: 6162451. DOI: 10.3390/jof4030092. View

4.
Constantino-Silva R, Perazzio S, Weidebach N, Grumach A . Functional Defect of Neutrophils Causing Dermatophytosis: Case Report. J Fungi (Basel). 2020; 6(4). PMC: 7712173. DOI: 10.3390/jof6040238. View

5.
Almeida-Paes R, Oliveira L, Oliveira M, Gutierrez-Galhardo M, Nosanchuk J, Zancope-Oliveira R . Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex. Biomed Res Int. 2015; 2015:212308. PMC: 4417584. DOI: 10.1155/2015/212308. View